Left Atrial Remodeling Predicts Cardiovascular Risk in Asymptomatic Diabetes Patients with Early CKD: Study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-06-10 17:30 GMT   |   Update On 2025-06-10 17:30 GMT

China: A recent study published in Reviews in Cardiovascular Medicine highlights the significance of left atrial structural and functional alterations in forecasting major cardiac complications in patients with type 2 diabetes mellitus (T2DM) and early-stage chronic kidney disease (CKD).

Led by Dr. Mingxia Gong and researchers from the Department of Echocardiography at The Third Affiliated Hospital of Soochow University, the study utilized advanced imaging techniques to assess whether changes in the left atrium (LA) could predict future cardiovascular events in this high-risk yet often overlooked population.

"In asymptomatic type 2 diabetes patients, progression of diabetic nephropathy was associated with higher LAVImin and lower LASr, both reflecting declining kidney function. These markers independently predicted major cardiovascular events (AUC: 0.818), emphasizing the value of LA strain analysis in early cardiorenal risk evaluation," the researchers reported.

Using four-dimensional automatic left atrial quantification (4D Auto LAQ), the team evaluated 361 individuals with asymptomatic T2DM and early CKD. The imaging measured LA volume indices, such as minimum (LAVImin), maximum, and pre-ejection volumes, and strain values reflecting LA function during reservoir, conduit, and contraction phases.

Over a median follow-up of nearly four years, 70 participants experienced major adverse cardiovascular events (MACEs), which included nonfatal myocardial infarction, stroke, heart failure, or cardiac death. Through detailed statistical analyses, including Cox proportional hazard models, the study identified two LA parameters as independent predictors of cardiovascular risk: increased LAVImin and reduced longitudinal strain during the reservoir phase (LASr).

The key findings of the study include the following:

  • Each unit increase in LAVImin was associated with a 21% higher risk of major adverse cardiovascular events (adjusted HR: 1.21).
  • Higher LASr values were linked to a significantly lower risk of cardiovascular events (adjusted HR: 0.81).
  • Patients with LAVImin >16.9 mL/m² had more than twice the risk of MACEs compared to those with LAVImin ≤16.9 mL/m².
  • Individuals with LASr <18.5% faced nearly a fourfold increased risk of MACEs compared to those with LASr ≥18.5%.
  • LASr was identified as the strongest echocardiographic predictor of cardiovascular events among the parameters studied.
  • The predictive accuracy of LAVImin and LASr for MACEs was high, with an AUC of 0.818.

The researchers emphasize that these structural and functional changes in the left atrium may reflect early cardiovascular stress due to underlying diabetic nephropathy, even in the absence of symptoms. As such, integrating 4D LA quantification—especially LASr—into routine cardiac evaluations could enhance early detection and risk stratification in T2DM patients with renal involvement.

"While further studies with larger populations are warranted, the results emphasize the clinical utility of LA remodeling parameters in guiding early intervention strategies aimed at reducing cardiovascular complications in diabetic patients with early kidney dysfunction," the authors concluded.

Reference:

Mingxia Gong, Min Xu, Suoya Pan, Shu Jiang, Xiaohong Jiang. Association of Left Atrium Remodeling With Major Adverse Cardiovascular Events in Asymptomatic Type 2 Diabetes Patients With Early Chronic Kidney Disease. Rev. Cardiovasc. Med. 2025, 26(5), 27247. https://doi.org/10.31083/RCM27247


Tags:    
Article Source : Reviews in Cardiovascular Medicine

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News